Parisa Badiee, Parivash Kordbacheh, Abdolvahab Alborzi, SeyedAli Malekhoseini, Farideh Zeini, Hosein Mirhendi, Mahmood Mahmoodi – 28 June 2007 – Invasive fungal infections after liver transplantation (LT) have resulted in high mortality and potentially fatal complications. This study was undertaken to determine the accuracy of the panfungal polymerase chain reaction enzyme link immunosorbent assay (PCR‐ELISA) method in early diagnosis of invasive fungal infections in liver transplant recipients (LTRs).

Nevin Yilmaz, Mitchell L. Shiffman, R. Todd Stravitz, Richard K. Sterling, Velimir A. Luketic, Arun J. Sanyal, A. Scott Mills, Melissa J. Contos, Adrian Coterell, Daniel Maluf, Marc P. Posner, Robert A. Fisher – 28 June 2007 – Recurrence of hepatitis C virus (HCV) following liver transplantation (LT) is universal. A subset of these patients develop advanced fibrosis and cirrhosis and it is believed that this leads to increased posttransplantation mortality.

Mingqing Xu, Lunan Yan, Jichun Zhao, Bo Li, Tianfu Wen, Yong Zeng, Yukui Ma, Wentao Wang, Jaying Yang, Zheyu Chen – 28 June 2007

Albert M. Harary, Kareem Abu‐Elmagd, Ngoc Thai, Ron Shapiro, Satoru Todo, John J. Fung, Thomas E. Starzl – 28 June 2007 – In July 1988, the liver and pancreas of a cadaveric donor were transplanted separately into a man with type 1 diabetes with end‐stage chronic hepatitis B virus. Two features of the operation may help explain the patient's current status as the longest‐lived liver‐pancreas recipient. One was enteric drainage of pancreatic exocrine secretions. The other was delivery of the pancreas venous effluent to the host portal system and then directly to the hepatic allograft.

Marcus Mottershead, James Neuberger – 28 June 2007

Adam G. Testro, Stephen O. Brennan, Richard A.L. Macdonell, Philip N. Hawkins, Peter W. Angus – 28 June 2007 – Liver transplantation (LT) has been reported in only 1 patient with hereditary variant apolipoprotein AI (apoAI) amyloidosis and was associated with a 50% decrease in production of variant apoAI. The potential for this to benefit clinical manifestations of apoAI amyloidosis such as peripheral neuropathy has not been determined.

Manuel Jimenez‐Saenz, Carmen Martinez‐Sanchez – 28 June 2007

28 June 2007

James D. Perkins – 28 June 2007 – Orthotopic liver transplantation (OLT) is the only curative therapy of HCC with underlying cirrhosis, but due to HCC metastasis and recurrence, its benefit is limited to a small population who meet the strict selection criteria. We previously reported that Licartin ([131I]mAb HAb18G/CD147) was safe and effective in treating HCC patients, and its antigen, HAb18G/CD147, was closely related to HCC invasion and metastasis. Here, we reported a randomized controlled trial to assess the post‐OLT antirecurrence efficacy of Licartin in advanced HCC patients.

Hugo Bonatti, Hannes Goegele, Dominique Tabarelli, Gilbert Muehlmann, Robert Sawyer, Raimund Margreiter, Walter Mark, Cornelia Lass Flörl – 28 June 2007